[HTML][HTML] Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
X Zhu, S Wu - Clinical Hypertension, 2022 - Springer
Background Rapid progress over the last decade has added numerous agents targeting
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
X Zhu, S Wu - Clinical Hypertension, 2022 - dbpia.co.kr
Rapid progress over the last decade has added numerous agents targeting specific cellular
signaling pathways to the treatment armamentarium for advanced cancer. However, many of …
signaling pathways to the treatment armamentarium for advanced cancer. However, many of …
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review.
X Zhu, S Wu - Clinical Hypertension, 2022 - europepmc.org
Background Rapid progress over the last decade has added numerous agents targeting
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
X Zhu, S Wu - Clinical Hypertension, 2022 - search.proquest.com
Background Rapid progress over the last decade has added numerous agents targeting
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
[HTML][HTML] Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
X Zhu, S Wu - Clinical Hypertension, 2022 - ncbi.nlm.nih.gov
Background Rapid progress over the last decade has added numerous agents targeting
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review.
X Zhu, S Wu - Clinical Hypertension, 2022 - search.ebscohost.com
Background: Rapid progress over the last decade has added numerous agents targeting
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
X Zhu, S Wu - Clinical Hypertension - KoreaMed
Background Rapid progress over the last decade has added numerous agents targeting
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
[HTML][HTML] Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
X Zhu, S Wu - Clinical Hypertension, 2022 - clinicalhypertension.biomedcentral …
Rapid progress over the last decade has added numerous agents targeting specific cellular
signaling pathways to the treatment armamentarium for advanced cancer. However, many of …
signaling pathways to the treatment armamentarium for advanced cancer. However, many of …
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
X Zhu, S Wu - Clinical hypertension, 2022 - pubmed.ncbi.nlm.nih.gov
Background Rapid progress over the last decade has added numerous agents targeting
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
specific cellular signaling pathways to the treatment armamentarium for advanced cancer …
Risks and management of hypertension in cancer patients undergoing targeted therapy: a review
X Zhu, S Wu - Clinical Hypertension, 2022 - kiss.kstudy.com
Rapid progress over the last decade has added numerous agents targeting specific cellular
signaling pathways to the treatment armamentarium for advanced cancer. However, many of …
signaling pathways to the treatment armamentarium for advanced cancer. However, many of …